Literature reviews, generated by AI
Ask a question. Get a review grounded in recent research.
PubMed research · Cited sources
Ask a question. Get a review grounded in recent research.
PubMed research · Cited sources
6 free credits, then one-time credit packs from $5.
Stent sizing in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) should reflect true reference-vessel dimensions, lesion morphology, crossing strategy, and the full extent of disease or procedural injury rather than the angiographic appearance of the occluded segment alone. Intravascular ultrasound (IVUS) is particularly valuable for defining vessel size, landing zones, calcium, dissection, intramural hematoma, and stent expansion, while optical coherence tomography (OCT) offers higher-resolution assessment in selected cases. The distal reference vessel generally provides the safest basis for nominal diameter selection in tapered anatomy, with proximal optimization when required. Stent length should cover the CTO, significant adjacent disease, and all relevant dissection, hematoma, or re-entry zones while avoiding geographic miss, unnecessary extension, and excessive overlap. Adequate lesion preparation and post-deployment imaging are essential, especially in calcified, long, tapered, overlapping, or subintimal lesions. Current evidence supports individualized, imaging-guided sizing and optimization but does not establish a universal CTO-specific sizing formula.
Question: How can we select stent size in CTO PCI: Criteria and Pitfalls
Read the full reviewPositive end-expiratory pressure (PEEP) is used in pediatric mechanical ventilation to preserve end-expiratory lung volume, prevent alveolar closure, improve oxygenation, and reduce cyclic recruitment and derecruitment. However, its effects vary according to age, chest-wall and respiratory-system mechanics, lung disease, recruitability, tidal volume, and cardiovascular reserve. Pediatric studies consistently support individualized titration rather than a fixed age-based value or adjustment based on oxygenation alone. Low-to-moderate PEEP can improve compliance and reduce driving pressure in anesthetized children, while higher PEEP may recruit lung units in some patients but cause overdistension, reduced compliance, impaired venous return, decreased cardiac output, and lower oxygen delivery in others. In pediatric acute respiratory distress syndrome (PARDS), PEEP is best integrated into a broader lung-protective strategy that includes appropriate tidal volume, pressure limitation, and careful assessment of oxygenation, respiratory mechanics, recruitability, and hemodynamics. Esophageal pressure monitoring may assist selected patients with abnormal chest-wall or pleural mechanics, although outcome evidence remains insufficient. Current evidence is predominantly physiological, observational, or implementation-based and does not establish a universal optimal PEEP or definitive patient-centered benefit.
Question: do a literature review in PEEP in pediatric ventilation
Read the full reviewTreatment-requiring retinopathy of prematurity (ROP) is managed primarily with laser photocoagulation or intravitreal anti–vascular endothelial growth factor (anti-VEGF) therapy, while selected milder peripheral disease may be observed with intensive surveillance. Laser provides established and often durable control, particularly for zone II type 1 ROP, but can be technically difficult in posterior or extensive disease and may contribute to peripheral retinal destruction, refractive error, and other ocular complications. Anti-VEGF agents, including bevacizumab, ranibizumab, aflibercept, and conbercept, are valuable alternatives for posterior, aggressive posterior, or extensive ROP. Available evidence indicates favorable short- and medium-term anatomical outcomes, with aflibercept showing outcomes broadly comparable to laser through three years and ranibizumab supporting regression in type 1 ROP and aggressive posterior ROP. Nevertheless, anti-VEGF therapy may be followed by late recurrence or delayed vascularization, requiring prolonged ophthalmic follow-up. Comparative evidence remains limited for some agents because several studies are retrospective, small, or insufficiently powered.
Question: effective interventions for retinopathy of prematurity
Read the full reviewThe supplied literature supports a focused review of California medical-legal developments affecting healthcare access, patient autonomy, public-health regulation, insurance, and professional liability from 2024 through 2026. The evidence concerns continuing implementation of earlier laws and judicial doctrines rather than a comprehensive inventory of new enactments. Major themes include reproductive-health access through pharmacies and emergency departments, interstate abortion-care burdens, vaccination-exemption oversight, HIV criminal-law reform, targeted physician-licensure pathways, medical aid in dying, involuntary treatment for severe substance-use disorders, Affordable Care Act litigation, and expanded causation theories in pharmaceutical and medical-device failure-to-warn cases. Across these areas, formal legal rights or powers do not determine practical outcomes by themselves. Access depends on training, staffing, reimbursement, institutional policy, documentation, continuity of care, procedural safeguards, and reliable evidence of effectiveness.
Question: Give me a detailed overview of newest developments in medical legal field in California in 2024-2026
Read the full reviewSuperior vena cava syndrome (SVCS) results from obstruction, stenosis, thrombosis, or external compression of the superior vena cava or its major tributaries, impairing venous drainage from the head, neck, upper extremities, and upper thorax. Malignancy remains a major adult cause, particularly lung cancer, lymphoma, and other mediastinal tumors, while catheter- and device-associated thrombosis has become increasingly important. Pediatric disease is strongly associated with mediastinal T-cell malignancies. Clinical severity depends on the location and rapidity of obstruction and the adequacy of collateral circulation. Symptoms range from facial and upper-extremity edema to airway compromise, cerebral venous congestion, and hemodynamic instability. Contrast-enhanced computed tomography is central to diagnosis and procedural planning. Management requires treatment of both the obstruction and its underlying cause. Supportive care, anticoagulation for documented thrombosis, tumor-directed therapy, endovascular recanalization and stenting, and selected surgical reconstruction each have appropriate roles. Endovascular treatment provides rapid palliation in severe malignant and benign disease, although restenosis, thrombosis, recurrence, and uncertainty regarding postprocedural antithrombotic therapy remain important limitations.
Question: Create literature review for superior vena caval syndrome
Read the full reviewGlucagon-like peptide-1 (GLP-1) is an incretin hormone released mainly by intestinal L cells after nutrient intake. Through glucose-dependent stimulation of insulin secretion, suppression of glucagon release during hyperglycemia, delayed gastric emptying, and promotion of satiety, GLP-1 improves glycemic regulation and reduces food intake. These actions support the use of GLP-1 receptor agonists (GLP-1RAs) in type 2 diabetes and chronic weight management. Semaglutide, liraglutide, dulaglutide, and exenatide produce clinically meaningful glycemic and weight-related benefits, while the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide often produces greater reductions in glycated hemoglobin and body weight. GLP-1RAs may also reduce cardiovascular outcomes in selected populations, although benefits are drug- and population-specific. Gastrointestinal adverse effects, loss of fat-free mass, treatment cost and tolerability, and weight regain after discontinuation remain important considerations. Current evidence supports individualized, long-term treatment accompanied by lifestyle and nutritional strategies, while highlighting the need for further direct comparisons and studies of durability, safety, and body composition.
Question: GLP-1
Read the full reviewThree-dimensional brain visualization from volumetric magnetic resonance imaging (MRI) combines high-resolution acquisition, preprocessing, anatomical segmentation, structural reconstruction, and interactive surface or volume rendering. The resulting patient-specific models can display cortical and subcortical anatomy, gyri, sulci, lesions, vessels, ventricles, cortical thickness, and selected functional or electrode-related data. Isotropic or near-isotropic imaging supports multiplanar reformation, whereas deformable atlas registration can improve visualization of structures that are difficult to distinguish on conventional MRI. In neurosurgical practice, MRI-based reconstructions may assist anatomical localization, trajectory selection, lesion mapping, and preoperative or intraoperative planning. Reported evidence also indicates close correspondence between reconstructed cortical anatomy and operative findings, with lesion-localization accuracy of approximately 2.6 ± 1.0 mm in one workflow. The available studies establish important acquisition and reconstruction principles, although they do not uniformly evaluate general-purpose clinical rendering systems.
Question: Give 3d view of mri brain
Read the full reviewHealthy living is most effectively developed through gradual, practical, and sustainable behaviors rather than rigid or extreme programs. The evidence presented supports a flexible approach centered on nutritious, minimally processed foods; regular physical activity; reduced sedentary time; adequate sleep; stress management; avoidance of tobacco; moderation of alcohol; and attention to individual circumstances. Mediterranean- and DASH-style eating patterns provide adaptable models, while walking, cycling, household activities, active transportation, and brief exercise sessions can make movement accessible. Small goals, self-regulation, social support, and professional guidance may improve adherence. Overall, consistency, enjoyment, and compatibility with personal preferences, resources, and daily responsibilities are more important than perfection.
Question: Summarize the key points of a healthy lifestyle to adopt easily and without hard constraints
Read the full reviewArginyl–tRNA synthetase (ArgRS; EC 6.1.1.19) catalyzes ATP-dependent attachment of L-arginine to cognate tRNA^Arg, producing arginyl-tRNA^Arg, AMP, and inorganic pyrophosphate. The reaction proceeds through amino-acid adenylation followed by transfer of arginine to a hydroxyl group of the terminal adenosine of tRNA. Evidence from kinetic, structural, mutational, and exchange studies indicates that Mg^2+ supports substrate binding and phosphoryl-transfer chemistry, while tRNA participates directly in formation and utilization of the activated arginine state. However, the binding order and accessibility of the Arg-AMP intermediate vary among systems: yeast studies support flexible substrate association and a tightly enzyme-associated activated state, whereas other analyses describe a detectable enzyme-bound aminoacyl-adenylate. Conformational rearrangements, pyrophosphate-dependent reversibility, and product release contribute to turnover in addition to ester-bond formation.
Question: Explain the mechanism of Arginine-tRNA ligase Q05506 UniProt EC 6.1.1.19. Explain which substrate it works on and the step by step mechanism from reactant to product
Read the full reviewPre-eclampsia is consistently associated with elevated cardiovascular risk extending well beyond pregnancy. Compared with women whose pregnancies are normotensive or uncomplicated, affected women have higher risks of chronic hypertension, coronary heart disease, myocardial infarction, heart failure, stroke and other cerebrovascular disease, arterial disease, cardiovascular hospitalization, and cardiovascular mortality. Across studies, later cardiovascular disease risk is generally approximately two- to fourfold higher, although estimates vary by population, outcome, and follow-up duration. Risk is particularly pronounced after early-onset, severe, preterm, or recurrent disease and when fetal growth restriction is present. The association is partly mediated by subsequent hypertension and cardiometabolic risk factors, while persistent vascular, cardiac, inflammatory, metabolic, and angiogenic abnormalities may also contribute. A history of pre-eclampsia therefore warrants lifelong cardiovascular risk assessment and prevention.
Question: what is the long term cardiovascular risk after pre-eclampsia?
Read the full review